ArticleThe Australasian journal of dermatology2026
Dupilumab as an Effective Adjuvant Therapy for Corticosteroid-Refractory Lichenoid-Bullous Dermatitis Secondary to Pembrolizumab.
Brandon Tan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.